Becker's Healthcare October 23, 2025
The high cost of GLP-1 drugs have thrown a curveball at payer strategy. Employers providing health insurance are also grappling with the fallout.
From January to July, Davis Research interviewed business owners and human resource and benefits managers at 1,862 firms for KFF. Some interviews addressed GLP-1 coverage for weight loss. For these questions, the researchers focused on organizations with at least 200 employees.
Here are five notes on how employers are handling GLP-1 coverage for weight loss:
1. The larger the company, the more likely it is to cover GLP-1 agonists for weight-loss use cases: 16% of firms with 200 to 999 workers, 30% of firms with 1,000 to 4,999 workers and 43% of firms with 5,000 or more...
Today's Sponsors
Today's Sponsor